1STBIO is Drug Discovery in South Korea that focus on operator business. Founded in 2016. They cover business area such as operator, degenerative brain disease, a deep pipeline, class, proper disease modification, good pharmacological property, healthcare professional, research ad development, therapy, neurodegenerative disease, immuno-oncology, rare disease.
2016
( 8 years old in 2024 )
Operator
-
Room 313, 240, Pangyoyeok-ro, Bundang-gu
Gyeonggi-do (Samhwan Hipex Building A)
Seongnam-si
South Korea
Private
operatordegenerative brain diseasea deep pipelineclassproper disease modificationgood pharmacological propertyhealthcare professionalresearch ad developmenttherapyneurodegenerative diseaseimmuno-oncologyrare disease
* We use standard office opening hours in near 1STBIO's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
1STBIO is Drug Discovery business from South Korea that founded in 2016 (8 years old in 2024), 1STBIO business is focusing on Operator.
1STBIO headquarter office and corporate office address is located in Room 313, 240, Pangyoyeok-ro, Bundang-gu Gyeonggi-do (Samhwan Hipex Building A) Seongnam-si South Korea.
1STBIO was founded in South Korea.
In 2024, 1STBIO is currently focus on operator sector.
Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with 1STBIO, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
